Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Coherus Bio (NQ: CHRS )

4.460 +0.320 (+7.73%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,705,948
Open 4.150
Bid (Size) 4.300 (28)
Ask (Size) 4.460 (30)
Prev. Close 4.140
Today's Range 4.140 - 4.475
52wk Range 3.600 - 10.99
Shares Outstanding 94,468,493
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Coherus BioSciences Announces New Employment Inducement Grants
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus Completes Surface Oncology Acquisition
From Coherus BioSciences, Inc.
Via GlobeNewswire

Performance

YTD
-47.59%
-47.59%
1 Month
-2.41%
-2.41%
3 Month
+17.06%
+17.06%
6 Month
-25.67%
-25.67%
1 Year
-50.99%
-50.99%

More News

Read More
Why Coherus BioSciences Stock Was Plunging This Week
Via The Motley Fool
Airbnb, Blackstone Rise On News They'll Join S&P 500 Index
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Why Coherus BioSciences Stock Popped Today
Via The Motley Fool
Coherus BioSciences to Participate at Upcoming September Investor Conferences
From Coherus BioSciences, Inc.
Via GlobeNewswire
Surface Oncology Announces ISS and Glass Lewis Both Recommend Stockholders Vote “FOR” the Proposed Merger with Coherus BioSciences
From Surface Oncology, Inc.
Via GlobeNewswire
Coherus BioSciences Announces New Employment Inducement Grants
From Coherus BioSciences, Inc.
Via GlobeNewswire
Analyst Ratings for Coherus BioSciences
Via Benzinga
Earnings Preview For Coherus BioSciences
Via Benzinga
10 Analysts Have This to Say About Coherus BioSciences
Via Benzinga
Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Clorox, Boot Barn, Herbalife, Upwork And Other Big Stocks Moving Higher On Thursday
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023
From Coherus BioSciences, Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For July 24, 2023
Via Benzinga
Coherus BioSciences Announces New Employment Inducement Grants
From Coherus BioSciences, Inc.
Via GlobeNewswire
Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
From Coherus BioSciences, Inc.
Via GlobeNewswire
Mark Cuban's Pharmacy Company Lands Deal With Top 10 US Retailer: Here Are The Details
Via Benzinga
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
From Coherus BioSciences, Inc.
Via GlobeNewswire
Cramer Is Still Bullish On AI Company Up 155% YTD: 'I Remain A Buyer'
Via Benzinga
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
From Coherus BioSciences, Inc.
Via GlobeNewswire
Synergy Of Coherus And Surface Oncology: Analyst Forecasts $50M Savings And 2024 Profitability
Via Benzinga
Nasdaq Down 80 Points; US Consumer Sentiment Surges To 4-Month High In June
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.